Abstract
The demonstration that mouse somatic cells can be reprogrammed following fusion with embryonic
stem (ES) cells may provide an alternative to somatic cell nuclear transfer (therapeutic
cloning) to generate autologous stem cells. In an attempt to produce cells with an increased
pool of reprogramming factors, tetraploid ES cells were produced by polyethylene glycol mediated
fusion of two ES cell lines transfected with plasmids carrying puromycin or neomycin
resistance cassettes, respectively, followed by double antibiotic selection. Tetraploid ES cells
retain properties characteristic of diploid ES cells, including the expression of pluripotent
gene markers
Get full access to this article
View all access options for this article.
